Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load

被引:65
|
作者
Quarantelli, M
Ciarmiello, A
Morra, VB
Orefice, G
Larobina, M
Lanzillo, R
Schiavone, V
Salvatore, E
Alfano, B
Brunetti, A
机构
[1] CNR, Ist Biostruct & Bioimmagini, I-80131 Naples, Italy
[2] IRCCS, Fdn G Pascale, Dept Diagnost Imaging, Naples, Italy
[3] Univ Naples Federico II, Dept Neurog Sci, Naples, Italy
[4] Univ Naples Federico II, Dept Diagnost Imaging, Naples, Italy
关键词
relapsing-remitting multiple sclerosis; MRI; brain atrophy; segmentation; brain volume;
D O I
10.1016/S1053-8119(02)00018-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The aim of this study was to simultaneously measure in vivo volumes of gray matter (GM), normal white matter (WM), abnormal white matter (aWM), and cerebro-spinal fluid (CSF), and to assess their relationship in 50 patients with relapsing-remitting multiple sclerosis (RR-MS) (age range, 21-59; mean EDSS, 2.5; mean disease duration, 9.9 years), using an unsupervised multiparametric segmentation procedure applied to brain MR studies. Tissue volumes were normalized to total intracranial volume providing corresponding fractional volumes (fGM, faWM, fWM, and fCSF), subsequently corrected for aWM-related segmentation inaccuracies and adjusted to mean patients' age according to age-related changes measured in 54 normal volunteers (NV) (age range 16-70). In MS patients aWM was 23.8 +/- 29.8 ml (range 0.4-138.8). A significant decrease in fGM was present in MS patients as compared to NV (49.5 3.2% vs 53.3 +/- 2.1%; P < 0.0001), with a corresponding increase in fCSF (13.0 +/- 3.8% vs 9.1 +/- 2.4%; P < 0.0001). No difference could be detected between the two groups for fWM (37.5 +/- 2.6% vs 37.6 +/- 2.2%). faWM correlated inversely with fGM (R = -0.434, P < 0.001 at regression analysis), and directly with fCSF (R 0.473, P < 0.001), but not with fWM. There was a significant correlation between disease duration and EDSS, while no relationship was found between EDSS or disease duration and fractional volumes. Brain atrophy in RR-MS is mainly related to GM loss, which correlates with faWM. Both measures do not appear to significantly affect EDSS, which correlates to disease duration. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:360 / 366
页数:7
相关论文
共 50 条
  • [21] Increased contrast enhancing lesion activity in relapsing-remitting multiple sclerosis migraine patients
    Graziano, Elliot
    Hagemeier, Jesper
    Weinstock-Guttman, Bianca
    Ramasamy, Deepa P.
    Zivadinov, Robert
    NEUROIMAGE-CLINICAL, 2015, 9 : 110 - 116
  • [22] Prognostic value of spinal cord lesion measures in early relapsing-remitting multiple sclerosis
    Lauerer, Markus
    McGinnis, Julian
    Bussas, Matthias
    El Husseini, Malek
    Pongratz, Viola
    Engl, Christina
    Wuschek, Alexander
    Berthele, Achim
    Riederer, Isabelle
    Kirschke, Jan S.
    Zimmer, Claus
    Hemmer, Bernhard
    Muehlau, Mark
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (01) : 37 - 43
  • [23] The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis
    Colette M. Griffin
    Declan T. Chard
    Geoff J. M. Parker
    Gareth J. Barker
    Alan J. Thompson
    David H. Miller
    Journal of Neurology, 2002, 249 : 193 - 199
  • [24] Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis
    Koudriavtseva, Tatiana
    Lorenzano, Svetlana
    Cellerino, Maria
    Truglio, Mauro
    Fiorelli, Marco
    Lapucci, Caterina
    D'Agosto, Giovanna
    Conti, Laura
    Stefanile, Annunziata
    Zannino, Silvana
    Filippi, Maria Maddalena
    Cortese, Antonio
    Piantadosi, Carlo
    Maschio, Marta
    Maialetti, Andrea
    Galie, Edvina
    Salvetti, Marco
    Inglese, Matilde
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [25] The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis
    Griffin, CM
    Chard, DT
    Parker, GJM
    Barker, GJ
    Thompson, AJ
    Miller, DH
    JOURNAL OF NEUROLOGY, 2002, 249 (02) : 193 - 199
  • [26] An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
    Saleem, Sidra
    Anwar, Arsalan
    Fayyaz, Muniba
    Anwer, Fatima
    Anwar, Faria
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
  • [27] Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis
    Meijboom, Rozanna
    York, Elizabeth
    Kampaite, Agniete J.
    Harris, Mathew
    White, Nicole
    Hernandez, Maria del C. Valdes
    Thrippleton, Michael
    MacDougall, N. J. J. D.
    Connick, Peter
    Hunt, David P. J.
    Chandran, Siddharthan
    Waldman, Adam
    FutureMS Consortium
    PLOS ONE, 2023, 18 (07):
  • [28] CONTEMPORARY TREATMENT OPTIONS FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Salhofer-Polanyi, S.
    Leutmezer, F.
    DRUGS OF TODAY, 2014, 50 (05) : 365 - 383
  • [29] Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
    Onder, Halil
    TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (02) : 105 - 106
  • [30] Parity and disability progression in relapsing-remitting multiple sclerosis
    Achiron, Anat
    Ben-David, Alon
    Gurevich, Michael
    Magalashvili, David
    Menascu, Shay
    Dolev, Mark
    Stern, Yael
    Ziv-Baran, Tomer
    JOURNAL OF NEUROLOGY, 2020, 267 (12) : 3753 - 3762